FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Coronary Drug-Eluting Stent

PMA: P100023 · Supplement: S100 · Decision Jun 4, 2014
Classifications
1
FEI Numbers
32
Registration Numbers
32

Basic Information

Device Name
Coronary Drug-Eluting Stent
Trade Name
ION PACLITAXEL-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
PMA Number
P100023
Supplement Number
S100
Device Class
FDA Class 3
Product Code
NIQ
Generic Name
Coronary drug-eluting stent
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
June 4, 2014
Date Received
May 5, 2014
Supplement Type
30-Day Notice
Expedited Review
N

Advisory Committee Statement

REMOVE THE MANUAL INSPECTION OF THE DISTANCE BETWEEN THE BI-COMPONENT ASSEMBLY (BOND) AND PROXIMAL BALLOON BOND.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NIQ Coronary Drug-Eluting Stent